🔥🐔 BizChicken 🐔🔥
Companies Similar to Lantern Pharma Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Longboard Pharmaceuticals, Inc.
LP352
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines for neurological diseases. Its lead product candidate, LP352, is in a clinical trial for treating seizures associated with developmental and epileptic encephalopathies. Based in La Jolla, California, the company was formerly known as Arena Neuroscience, Inc.
Symbol: LBPH
Recent Price: $59.98
Industry: Biotechnology
CEO: Mr. Kevin R. Lind
Sector: Healthcare
Employees: 50
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 619 592 9775
Last updated: 2024-12-31
Lyell Immunopharma, Inc.
LYL797, LYL845, NY-ESO-1
Lyell Immunopharma, Inc. is a biopharmaceutical company developing T cell therapies focused on treating patients with solid tumors using advanced genetic and epigenetic reprogramming technologies.
About | Our Story | Vision/Values | Our Story | Leadership | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: LYEL
Recent Price: $0.62
Industry: Biotechnology
CEO: Dr. Lynn Seely M.D., Ph.D.
Sector: Healthcare
Employees: 224
Address: 201 Haskins Way, South San Francisco, CA 94080
Phone: 650 695 0677
Leadership
- Lynn Seely, M.D., President & Chief Executive Officer
- Stephen Hill, Chief Operating Officer
- Matthew Lang, J.D., Chief Business Officer
- Gary Lee, Ph.D., Chief Scientific Officer
- Charles Newton, Chief Financial Officer
- Ellen Rose, Senior Vice President, Investor Relations and Communications
- Bryan Selby, Senior Vice President, Clinical Development Operations
- Ann Tomlin, Senior Vice President, Human Resources
- Rick Klausner, M.D., Founder & Board Chair
- Crystal Mackall, M.D., Founder
- Stan Riddell, M.D., Founder
- Hans Bishop, Director
- Otis Brawley, M.D., Director
- Catherine Friedman, Director
- Elizabeth Nabel, M.D., Director
- Robert Nelsen, Director
- William Rieflin, Director
Last updated: 2024-12-31
Lixte Biotechnology Holdings, Inc.
LB-100 series and LB-200 series
Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.
Symbol: LIXT
Recent Price: $2.00
Industry: Biotechnology
CEO: Mr. Bastiaan van der Baan M.Sc.
Sector: Healthcare
Employees: 3
Address: 680 East Colorado Boulevard, Pasadena, CA 91101
Phone: 631 830 7092
Last updated: 2024-12-31
Lipella Pharmaceuticals Inc.
LP-10, LP-310
Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing drugs by reformulating active agents in existing generic drugs for various applications, including LP-10 for radiation-induced hemorrhagic cystitis and LP-310 for oral lichen planus.
Symbol: LIPO
Recent Price: $3.12
Industry: Biotechnology
CEO: Dr. Jonathan Kaufman M.B.A., Ph.D.
Sector: Healthcare
Employees: 5
Address: 7800 Susquehanna St., Pittsburgh, PA 15208
Phone: 412-894-1853
Last updated: 2024-12-31
Lexicon Pharmaceuticals, Inc.
Sotagliflozin, LX9211
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.
About | Foundation | Leadership | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: LXRX
Recent Price: $0.72
Industry: Biotechnology
CEO: Dr. Michael Exton Ph.D.
Sector: Healthcare
Employees: 285
Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381
Phone: 281 863 3000
Leadership
- Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
- Brian Crum, Senior Vice President and General Counsel
- Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
- Mike Exton, Ph.D., Chief Executive Officer and Director
- Tom Garner, Senior Vice President and Chief Commercial Officer
- Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
- Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
- Wendy McDermott, Senior Vice President, Human Resources
- Kristen Alexander, Vice President, Finance and Accounting
- Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
- Kyle Burt, Vice President, Information Operations
- Amy Carroll, Ph.D., Vice President, Medical Affairs
- Melinda Francini, Vice President, Value and Access
- Desiree Gendron, Vice President, Sales and Training
- Suma Gopinathan, Ph.D., Vice President, Clinical Development
- Rachel Martens, Vice President, Partnerships and Corporate Strategy
- Nicole Moore, Vice President, Legal
- Tracy Newbold, Vice President, Clinical Operations
- Godfried Owusu-Ababio, Vice President, Technical Operations
- Rob Scala, Vice President, Business Planning and Commercial Operations
- Carrie Siragusa, Vice President, Marketing
- Dixon Terry, Vice President, Compliance
- Raymond Debbane, Chairman
- Philippe J. Amouyal,
- Samuel L. Barker, PhD,
- Robert J. Lefkowitz, MD,
- Christopher J. Sobecki,
- Diane E. Sullivan,
- Judith L. Swain, MD,
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
180 Life Sciences Corp.
Therapeutics for chronic pain, inflammation, fibrosis, and inflammatory diseases
1180 Life Sciences Corp. is a clinical-stage biotechnology company focused on developing therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis, using platforms such as fibrosis and anti-TNF, synthetic CBD analogs, and a7n ACh R.
Symbol: ATNF
Recent Price: $2.98
Industry: Biotechnology
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Sector: Healthcare
Employees: 4
Address: Building 4, Palo Alto, CA 94306
Phone: 650 507 0669
Last updated: 2024-11-08
Greenwich LifeSciences, Inc.
GP2
Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.
Symbol: GLSI
Recent Price: $10.91
Industry: Biotechnology
CEO: Mr. Snehal S. Patel
Sector: Healthcare
Employees: 3
Address: Building 14, Stafford, TX 77477
Phone: 832 819 3232
Last updated: 2024-12-31
Legend Biotech Corporation
LCAR-B38M
Legend Biotech Corporation is a clinical-stage biopharmaceutical company focusing on the discovery and development of novel cell therapies for oncology and other indications globally.
About | Our Story | Leadership | About | About | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | About | About
Symbol: LEGN
Recent Price: $32.77
Industry: Biotechnology
CEO: Dr. Ying Huang Ph.D.
Sector: Healthcare
Employees: 2200
Address: 2101 Cottontail Lane, Somerset, NJ 08873
Phone: 732 317 5050
Leadership
- Ying Huang, Ph.D., CHIEF EXECUTIVE OFFICER
- Guowei Fang, Ph.D., CHIEF SCIENTIFIC OFFICER AND HEAD OF BUSINESS DEVELOPMENT
- Lori Macomber, CHIEF FINANCIAL OFFICER
- Mythili Koneru, M.D., Ph.D., CHIEF MEDICAL OFFICER
- Jim Pepin, GENERAL COUNSEL
- Steve Gavel, SENIOR VICE PRESIDENT, COMMERCIAL DEVELOPMENT, US & EUROPE
- Yuhong Qiu, Ph.D., SENIOR VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS
- Birk Vanderweeën, SENIOR VICE PRESIDENT, GLOBAL MANUFACTURING & SUPPLY
- Alan Kick, SENIOR VICE PRESIDENT, GLOBAL QUALITY
- Doug Wallace, VICE PRESIDENT, GLOBAL OPERATIONS
- Elaine Qian, VICE PRESIDENT, GLOBAL HEAD OF HUMAN RESOURCES
- Tim Roberts, Global Compliance Officer
- Simon Wu, Senior Vice President, General Manager, Greater China
- Frank Zhang, EMBA, Ph.D., CHAIRMAN OF THE BOARD, LEGEND BIOTECH
- Sally Wang, M.S., PRESIDENT, GENSCRIPT
- Zhu Li, Ph.D., CHIEF STRATEGY OFFICER, GENSCRIPT
- Corazon (Corsee) Dating Sanders, Ph.D., CO-CHAIR OF THE BOARD OF ADVISORS, FRED HUTCH CANCER CENTER
- Darren Ji, M.D., Ph.D. and MBA, CHAIRMAN AND CEO, ELPISCIENCE BIOPHARMACEUTICALS
- Philip Yau, CHIEF FINANCIAL OFFICER. C&J CLARK
- Patrick Casey, Ph.D., SENIOR VICE DEAN OF RESEARCH, DUKE-NUS MEDICAL SCHOOL SINGAPORE AND A JAMES B. DUKE PROFESSOR OF PHARMACOLOGY AND CANCER BIOLOGY, DUKE UNIVERSITY
- Tomas J. Heyman, CEO, INTERLAKEN THERAPEUTICS
- Li Mao, M.D., CHIEF MEDICAL OFFICER, SCICLONE PHARMACEUTICALS
- Peter Salovey, Ph.D., Chris Argyris Professor of Psychology; Professor of Management, Epidemiology & Public Health, and Sociology; and President Emeritus of Yale University
- Michel Vounatsos, FORMER CEO OF BIOGEN INC.
- John Maraganore, Ph.D., FORMER CEO OF ALNYLAM PHARMACEUTICALS
Last updated: 2024-12-31
Lipocine Inc.
TLANDO
Lipocine Inc. is a clinical-stage biopharmaceutical company focused on developing pharmaceutical products for neuroendocrine and metabolic disorders using oral delivery solutions. Its lead product is TLANDO, an oral testosterone replacement therapy.
Symbol: LPCN
Recent Price: $4.58
Industry: Biotechnology
CEO: Dr. Mahesh V. Patel Ph.D.
Sector: Healthcare
Employees: 17
Address: 675 Arapeen Drive, Salt Lake City, UT 84108
Phone: 801 994 7383
Last updated: 2024-12-31
Lantern Pharma Inc.
LP-100
Lantern Pharma Inc. is a clinical stage biotechnology company focused on using artificial intelligence, machine learning, and genomic data to streamline drug development, with key drug candidates including LP-100, LP-300, and LP-184 for various cancer treatments.
About | About | About | About | Contact | About | Careers | Careers | About | About | About | About | About | About | About | About | About
Symbol: LTRN
Recent Price: $3.27
Industry: Biotechnology
CEO: Mr. Panna Sharma PH.D.
Sector: Healthcare
Employees: 21
Address: 1920 McKinney Avenue, Dallas, TX 75201
Phone: 972 277 1136
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
Pliant Therapeutics, Inc.
PLN-74809
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for the treatment of fibrosis and related diseases. Their lead product candidate, PLN-74809, is currently in Phase 2a trials.
Symbol: PLRX
Recent Price: $12.79
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Sector: Healthcare
Employees: 166
Address: 260 Littlefield Avenue, South San Francisco, CA 94080
Phone: 650 481 6770
Last updated: 2024-12-31
Silo Pharma, Inc.
SPC-15
Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.
Symbol: SILO
Recent Price: $0.89
Industry: Biotechnology
CEO: Mr. Eric Weisblum
Sector: Healthcare
Employees: 3
Address: 677 N. Washington Boulevard, Sarasota, FL 34236
Phone: 718 400 9031
Last updated: 2024-12-31
Sonnet BioTherapeutics Holdings, Inc.
SON-1010, SON-080
Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.
Symbol: SONN
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Pankaj Mohan Ph.D.
Sector: Healthcare
Employees: 12
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609-375-2227
Leadership
- Pankaj Mohan, Ph.D., Founder, CEO & Chairman
- Jay Cross, Chief Financial Officer
- John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
- Susan Dexter, Chief Technical Officer
- Richard Kenney, M.D., Chief Medical Officer
- Albert Dyrness, Board Member
- Nailesh Bhatt, Chief Executive Officer & Board Member
- Raghu Rao, Board Member
- Donald Griffith, Financial Controller
- Lori McNeill, Board Member
Last updated: 2024-12-31
BridgeBio Pharma, Inc.
AG10, BBP-265, BBP-831, BBP-631, Encaleret
Bridge Bio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases, with a pipeline of 30 programs including candidates like AG10, BBP-265, and others in various stages of clinical trials.
About | About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: BBIO
Recent Price: $27.32
Industry: Biotechnology
CEO: Dr. Neil Kumar Ph.D.
Sector: Healthcare
Employees: 550
Address: 421 Kipling Street, Palo Alto, CA 94301
Phone: 650 391 9740
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08